文献速递瓣膜外科

老年退行性二尖瓣病变:修复与置换的STS数据库分析

Mitral Valve Repair Versus Replacement in Elderly With Degenerative Disease: Analysis of the STS Adult Cardiac Surgery Database.
PubMed 文献 · Ann Thorac Surg · 2018-10-26

基于STS成人心脏手术数据库,纳入≥70岁因退行性病变行初次孤立择期二尖瓣修复或置换的患者12,043例,71%接受修复。修复组30天观察死亡率低于置换组(2.2%对4.8%,p<0.0001),调整后置换死亡风险更高(OR 1.83,95%CI 1.45–2.31)。修复失败率7.9%,其30天死亡率为6%。

要点

  • ≥70岁退行性二尖瓣病变,修复较置换的30天死亡率更低。
  • 保留腱索的置换仍劣于修复(OR 1.66,95%CI 1.28–2.14)。
  • 修复失败率7.9%,失败后短期获益减弱。

核心结论

  • 在≥70岁退行性二尖瓣病变患者中,修复与较低的 operative mortality 相关,且不受腱索保留策略影响。
  • 修复失败会削弱短期获益,意向治疗分析中与保留腱索的置换 operative mortality 相近。

研究设计与样本

  • 基于STS成人心脏手术数据库(版本2.73和2.81)的回顾性队列分析。
  • 纳入≥70岁行初次孤立择期二尖瓣修复或置换的退行性病变患者,共12,043例,71%接受修复。
  • 允许合并三尖瓣手术、房颤手术或房间隔缺损/卵圆孔未闭修补。
  • 按年龄分层:70–74岁、75–79岁、≥80岁。

主要发现

  • 修复组30天观察死亡率为2.2%,置换组为4.8%(p<0.0001)。
  • 以修复为参照,全队列调整后置换的 operative mortality 更高(OR 1.83,95%CI 1.45–2.31)。
  • 修复中完全与部分腱索保留的死亡率无显著差异(OR 1.24,95%CI 0.80–1.93)。
  • 保留腱索的置换仍劣于修复(OR 1.66,95%CI 1.28–2.14)。
  • 修复失败率为7.9%,其30天死亡率为6%。

关键数值与推荐

  • 年龄≥70岁、退行性二尖瓣病变、初次孤立择期手术。
  • 修复组30天死亡率2.2%,置换组4.8%(p<0.0001)。
  • 调整后置换 vs 修复的 operative mortality OR 1.83(95%CI 1.45–2.31)。
  • 修复失败率7.9%,失败后30天死亡率6%。

临床怎么用

  • 对≥70岁退行性二尖瓣病变患者,优先考虑修复以降低短期死亡风险。
  • 即使保留腱索,置换的短期死亡率仍高于修复。
  • 需关注修复失败风险,失败后短期获益减弱。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It has been postulated that mitral valve repair in the elderly does not confer short-term benefits over mitral valve replacement with complete preservation of the chordal apparatus. Our purpose was to test this hypothesis using data from The Society of Thoracic Surgeons Adult Cardiac Surgery Database (STS ACSD). METHODS: Patients aged 70 years or more undergoing primary isolated elective mitral valve repair or mitral valve replacement for degenerative disease were obtained from the STS ACSD versions 2.73 and 2.81. Patients with a concomitant tricuspid procedure, atrial fibrillation surgery, or atrial septal defect/patent foramen ovale repair were included. The two treatment groups were further stratified by age in years (70 to 74, 75 to 79, and 80 or more). Adjusted 30-day mortality rates were analyzed by mitral procedure and chordal preservation strategy. RESULTS: The study included 12,043 patients, of whom 71% underwent mitral valve repair. Observed 30-day mortality after repair was lower than after replacement (2.2% versus 4.8%, respectively; p < 0.0001). Using repair as reference, adjusted operative mortality was higher for replacement in the overall cohort (odds ratio 1.83, 95% confidence interval: 1.45 to 2.31). There was no significant difference in mortality between complete versus partial chordal preservation in repair (odds ratio 1.24, 95% confidence interval: 0.80 to 1.93). Mitral valve replacement with chordal preservation remained inferior to repair (odds ratio 1.66, 95% confidence interval: 1.28 to 2.14). The failed repair rate was 7.9%, with a 30-day mortality of 6%. CONCLUSIONS: In patients aged 70 years or more, degenerative mitral repair was associated with lower operative mortality compared with replacement, irrespective of chordal preservation strategy. Failed repairs reduced this short-term benefit compared with chordal-sparing replacement as evidenced by the similar operative mortality on an intention to treat analysis.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Hendrix RJ, Bello RA, Flahive JM, et al. Mitral Valve Repair Versus Replacement in Elderly With Degenerative Disease: Analysis of the STS Adult Cardiac Surgery Database. Ann Thorac Surg. 2018. PMID: 30612990. doi:10.1016/j.athoracsur.2018.09.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。